Global Bone Cement and Glue Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Bone Cement and Glue Market Analysis

The bone cement and glue market is experiencing significant growth due to the increasing prevalence of orthopedic procedures, including joint replacements and spinal surgeries. Bone cements and glues are critical in providing stability during these surgeries, especially in arthroplasty, kyphoplasty, and vertebroplasty. These materials enhance the fixation of implants and promote faster healing. The market is driven by advancements in material science, resulting in improved performance, biocompatibility, and reduced complications for patients. Recently, the development of high-strength and bioactive bone cements has enhanced the effectiveness of surgeries. The market is also seeing a surge in minimally invasive techniques, further increasing demand. Key players are focusing on product innovation and partnerships with hospitals and surgical centers to drive growth. As the global aging population increases and the demand for orthopedic procedures rises, the bone cement and glue market is poised for continued expansion, especially in emerging regions with improving healthcare infrastructure.

Bone Cement and Glue Market Size

The global bone cement and glue market size was valued at USD 449.29 billion in 2023 and is projected to reach USD 686.90 billion by 2031, with a CAGR of 5.45% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Bone Cement and Glue Market Trends

“Increasing Demand for Orthopedic Procedures”

The bone cement and glue market is witnessing significant trends driven by technological innovations and the increasing demand for orthopedic procedures. Advancements in bone cement formulations, such as the development of bioactive and injectable cements, are improving surgical outcomes by enhancing bone integration and reducing complications. One notable trend is the rise in minimally invasive surgery, which is driving the demand for more efficient and easier-to-apply bone cement products. Innovations such as smart bone cements that monitor pressure during application are further enhancing precision in surgeries. This shift toward advanced and more reliable materials is boosting the adoption of bone cement and glue, particularly in aging populations and regions with growing healthcare needs. The market is set to grow as the technology evolves, offering better solutions for patients and healthcare providers.

Report Scope and Bone Cement and Glue Market Segmentation      

Bone Cement and Glue Market Definition

Bone cement and glue are medical adhesives used in orthopedic surgeries to anchor implants or stabilize bone fractures. Bone cement, typically made from polymethyl methacrylate (PMMA), is a widely used material in joint replacement surgeries such as hip, knee, and shoulder arthroplasty. It helps to secure prosthetic components to the bone, providing stability and promoting better fixation. Bone glue, on the other hand, is a more recent development, designed to offer stronger bonding properties and better biocompatibility. It is often used in minimally invasive procedures, fracture fixation, and spinal surgeries.

Bone Cement and Glue Market Dynamics

Drivers

• Increasing Prevalence of Orthopedic Conditions

The increasing prevalence of musculoskeletal disorders, such as osteoarthritis and osteoporosis, is a significant factor driving the demand for joint replacement surgeries and spinal procedures. As these conditions lead to joint degradation and bone fragility, surgeries such as hip, knee, and shoulder replacements are becoming more common. The aging population, which is more susceptible to these disorders, further accelerates the need for these procedures. Bone cement and glue play a crucial role in securing implants and providing stability during these surgeries, ensuring better fixation and promoting faster recovery. This growing demand for joint replacements and spinal procedures is directly contributing to the expansion of the bone cement and glue market.

• Demand for Minimally Invasive Surgeries

The growing trend of minimally invasive procedures in orthopedic surgery is significantly driving the demand for advanced bone cement and glue. These procedures, which involve smaller incisions and quicker recovery times, require materials that are easier to apply and offer strong, reliable fixation in tight spaces. Advanced bone cement formulations, including injectable and bioactive options, provide the necessary stability while minimizing the invasiveness of the surgery. The ability to apply these materials with precision in smaller surgical sites enhances the effectiveness of minimally invasive procedures, contributing to the broader adoption of these techniques and driving growth in the bone cement and glue market.

Opportunities

• Innovation in Bone Cement Formulations

The development of advanced bone cements, including bioactive and injectable formulations, presents a significant market opportunity by improving both patient outcomes and surgical efficiency. These new-generation bone cements offer superior biocompatibility, which enhances healing and reduces complications compared to traditional options. Their ease of use, particularly in minimally invasive procedures, allows for better precision and faster recovery times. The growing adoption of spinal and joint replacement surgeries, coupled with the need for more effective materials in these complex procedures, creates a strong demand for these advanced cements. This trend is driving market expansion and creating new opportunities for growth.

• Expanding Use in Trauma and Fracture Fixation

Bone cement and glue are finding growing applications in trauma care, particularly for fracture fixation, presenting new opportunities for market growth. These materials offer strong, reliable fixation, ensuring stability for fractured bones, which is critical in emergency and trauma settings. The increasing incidence of bone fractures, particularly in aging populations and accident victims, has led to a greater need for advanced fracture management solutions. As trauma care evolves with a focus on quicker recovery and enhanced patient outcomes, the demand for high-performance bone cement and glue is expanding beyond traditional joint replacement surgeries, driving new market opportunities in the trauma care sector.

Restraints/Challenges

• Limited Awareness in Emerging Markets

In several developing regions, there is a lack of awareness regarding the benefits and advancements in bone cement and glue technology, which hinders their adoption. Healthcare professionals in these areas may not be fully educated on the advantages of using advanced bone cement materials, such as bioactive and injectable formulations, for improved patient outcomes. This knowledge gap can result in reliance on traditional, less-effective products, limiting the overall growth of the bone cement and glue market. The challenge lies in educating healthcare providers and raising awareness about the potential benefits, which is essential for expanding the market in these regions.

•  High Cost of Advanced Materials

The high cost of advanced bone cement and glue, particularly bioactive and injectable options, presents a significant market restraint. These premium materials are often more expensive than traditional bone cements, limiting their accessibility in regions with constrained healthcare budgets. Developing countries, in particular, may face challenges in adopting these advanced solutions due to cost barriers, opting for more affordable, conventional alternatives instead. This pricing issue can hinder the broader global adoption of advanced bone cements, slowing market growth. For widespread use, reducing costs or providing financial incentives may be necessary to ensure greater accessibility and affordability in these regions.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Bone Cement and Glue Market Scope

The market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Bone Cement
  • Polymethyl Methacrylate (PMMA) Cement
  • Calcium Phosphate Cement (CPC)
  • Glass Polyalkenoate Cement (GPC)
  • Antibiotic-loaded Bone Cement
  • Non-antibiotic-loaded Bone Cement
• Bone Glue
  • Natural Bone Glue
  • Synthetic Bone Glue

Application

• Arthroplasty
• Total Knee Arthroplasty
• Total Hip Arthroplasty
• Total Shoulder Arthroplasty
• Kyphoplasty
• Vertebroplasty

End-User

• Hospitals
• Ambulatory Surgical Centers
• Clinics

 Bone Cement and Glue Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the bone cement and glue market, driven by a high prevalence of sports injuries and a growing number of road traffic accidents. These factors contribute to an increased demand for bone fixation solutions. Additionally, the region's advanced healthcare infrastructure and adoption of cutting-edge technologies further support market dominance.

Asia Pacific is expected to witness significant growth in the bone cement and glue market due to increasing healthcare investments, expanding aging populations, and a rising prevalence of bone-related disorders. Enhanced access to advanced medical technologies and improving healthcare infrastructure across the region are further contributing to the demand for effective solutions such as bone cement and glue. Additionally, the growing number of trauma cases and joint surgeries in countries such as India and China presents substantial opportunities for market growth during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Bone Cement and Glue Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Bone Cement and Glue Market Leaders Operating in the Market Are:

• 3M (U.S.)
• Essity Health & Medical (Germany)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• Heraeus Group (Germany)
• Smith & Nephew (U.K.)
• Enovis Corporation (U.S.)
• Medtronic (Ireland)
• Globus Medical (U.S.)
• Johnson & Johnson Services Inc. (U.S.)
• Arthrex Inc. (U.S.)
• aap Implantate AG (Germany)
• Exactech, Inc. (U.S.)
• Teknimed (France)
• Artivion, Inc (U.S.)
• Cardinal Health (U.S.)
• Demetra Holding S.p.A. (Italy)
• Orthofix Medical Inc. (U.S.)

Latest Developments in Bone Cement and Glue Market

• In February 2024, Exactech, a leader in joint replacement surgery innovations, partnered with Statera Medical to develop the world’s first smart reverse shoulder implant. This groundbreaking collaboration aims to combine Exactech's expertise in implants and instruments with Statera Medical's advanced technology. The new implant is expected to revolutionize shoulder replacement procedures with its smart, connected features
• In March 2024, Stryker (NYSE: SYK), a global leader in medical technology, announced the completion of its acquisition of SERF SAS, a French joint replacement company, from Menix. This acquisition strengthens Stryker’s portfolio in the joint replacement market. It is expected to enhance Stryker's offerings and expand its presence in the global orthopedic sector
• In September 2023, HippoFi, Inc. announced a strategic partnership with Zimmer Biomet to revolutionize the spinal biologics sector. The collaboration aims to launch an innovative synthetic biomaterial designed to promote bone growth, set for release in 2024 under HippoFi's biologic subsidiary, PUR Biologics. Additionally, HippoFi/PUR secured FDA 510(K) clearance for their ActiveOrbTM technology and obtained an exclusive global license from Zimmer Biomet for the spinal market
• In 2021, Smith & Nephew (UK) acquired Integra Life Sciences' Extremity Orthopedics business to enhance its product offerings in shoulder, upper, and lower extremities. This strategic acquisition aimed to broaden Smith & Nephew's portfolio in orthopedic solutions. It reflects the company's commitment to strengthening its position in the global extremities market
• In 2021, Zimmer Biomet (US) completed the spinoff of its spine and dental businesses into a new publicly traded company, ZimVie Inc. ("ZimVie"). This strategic move was designed to sharpen the focus of both Zimmer Biomet and ZimVie on meeting the specific needs of patients and customers. The transaction aimed to maximize value for stockholders by allowing both companies to concentrate on their core areas of expertise

SKU-27137